Trials / Completed
CompletedNCT03789357
Prevalence of Primary Aldosteronism in Patients With Stroke
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (actual)
- Sponsor
- Changi General Hospital · Academic / Other
- Sex
- All
- Age
- 21 Years – 80 Years
- Healthy volunteers
- —
Summary
Strokes leads to significant morbidity and mortality, and hypertension is the most important risk factor for strokes. It is estimated that up to 10% of patients with hypertension have the underlying, treatable condition of primary aldosteronism. Hence, we hypothesize that the prevalence of primary aldosteronism is high in patients with strokes, a complication of long-standing hypertension. Patients admitted with an acute stroke to the Acute Stroke Unit, Changi General Hospital, will be screened for Primary Aldosteronism three months post-stroke, and confirmatory tests will be done with saline-infusion test.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Aldosterone renin ratio | Aldosterone Renin Ratio to screen for Primary Aldosteronism |
Timeline
- Start date
- 2018-05-01
- Primary completion
- 2021-07-31
- Completion
- 2021-09-30
- First posted
- 2018-12-28
- Last updated
- 2022-05-20
Locations
1 site across 1 country: Singapore
Source: ClinicalTrials.gov record NCT03789357. Inclusion in this directory is not an endorsement.